2017 American Transplant Congress
Transcript Changes Associated with Graft Rejection Are Not Specific for Rejection Because They Are Shared with Tissue Responses to Wounding.
University of Alberta, Edmonton, Canada
The diagnosis of rejection by histology is based on the presence of relatively non-specific lesions. This is because the histology lesions are actually non-specific, but…2017 American Transplant Congress
Angioplasty versus Stent in the Treatment of Transplant Renal Artery Stenosis.
Objective: To compare restenosis rates and treatment efficacy between percutaneous transluminal angioplasty and stent placement in the treatment of transplant renal artery stenosis.Methods: We conducted…2017 American Transplant Congress
Renal Transplant Outcomes in Primary FSGS Compared with Other Recipients: A National Review of the Irish Transplant Registry.
Primary focal segmental glomerular sclerosis (p-FSGS) raises specific peri-transplant concerns, one of which is disease recurrence (r-FSGS). We aimed to compare transplant outcomes in patients…2017 American Transplant Congress
Using Basiliximab Does Not Increase De Novo DSA Incidence but Reduces Cytomegalovirus Infections and Neoplastic Complications in Non-Sensitized Kidney Transplant Patients.
Background. In kidney transplantation, de novo donor specific antibodies (dnDSA) are associated with antibody-mediated rejection (AMR) and graft failure. After dnDSA development, 24% of the…2017 American Transplant Congress
Controlled Donation After Circulatory Death (cDCD) Donors May Become Similar to Brain Death Donors (DBD).
Since 2014 in France, we started a cDCD program characterized by the introduction of normothermia regional perfusion (nRP) and selection criteria as donor age ≤65…2017 American Transplant Congress
Characteristics and Performance of Unilateral Deceased Donor Kidney Transplants.
1Columbia Univ, New York, NY; 2Emory Univ, Atlanta, GA
Purpose:The fraction of kidneys procured for transplant that are discarded is rising in the United States. Identifying donors from whom only one kidney was discarded…2017 American Transplant Congress
Association Between Transportation Strategies and Kidney Transplant Center Staff Perceived Racial Disparities.
Department of Surgery, Emory University, Atlanta, GA
Background: Racial disparities exist in access to the transplant evaluation process. One contributing factor for this disparity is travel barriers. Transplant center policies to assist…2017 American Transplant Congress
Renal Transplant Recipients with Indication for Antiplatelet Therapy: Increased Risk for the Allograft?
General Visceral and Transplantation Surgery, University Hospital, Essen, Germany
Background Antiplatelet therapy is common in patients on the waiting list for kidney transplantation increasing the risk for perioperative blood loss. This study evaluates the…2017 American Transplant Congress
TNF[part]-I After Kidney Transplantation.
Department of Medicine, Division of Nephrology, University of Wisconsin, Madison, WI
Infliximab, adalimumab and etanercept are monoclonal antibodies which inhibit tumor necrosis factor alpha (TNF[part]-I) and are used in the treatment of inflammatory diseases such as…2017 American Transplant Congress
The Effiency and Safety of Chemotherapy for Urothelial Carcinoma in Post-Kidney Transplanted Patients.
Urology, Capital Medical University Beijing Friendship Hospital, Beijing, China
Objective: According to our published data, upper tract urothelial carcinoma (UTUC) is the predominant malignancy among Chinese renal transplanted patients. This is quite different from…
- « Previous Page
- 1
- …
- 396
- 397
- 398
- 399
- 400
- …
- 531
- Next Page »